KENNETH B LEE JR Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KENNETH B LEE JR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KENNETH B LEE JR. KENNETH B LEE JR is Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in ABGENIX INC ($ABGX) and Director in POZEN INC /NC ($POZN) and Director in Aralez Pharmaceuticals Inc. ($ARLZ) and Director in EYENOVIA, INC. ($EYEN).
Latest Insider Trading Transactions of KENNETH B LEE JR
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABGX, BCRX, EYEN, ARLZ, POZN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 15 2020 | EYEN | EYENOVIA, INC. | LEE KENNETH B JR | Director | Option Exercise | A | 3.43 | 9,820 | 33,683 | 9,820 | |
Sep 15 2020 | EYEN | EYENOVIA, INC. | LEE KENNETH B JR | Director | Grant | A | 0.00 | 7,288 | 0 | 19,359 | 12.1 K to 19.4 K (+60.38 %) |
May 14 2020 | BCRX | BIOCRYST PHARMACEU ... | LEE KENNETH B JR | Director | Option Exercise | A | 5.41 | 40,000 | 216,400 | 40,000 | |
Nov 18 2019 | BCRX | BIOCRYST PHARMACEU ... | LEE KENNETH B JR | Director | Buy | P | 1.45 | 5,000 | 7,250 | 15,252 | 10.3 K to 15.3 K (+48.77 %) |
Aug 20 2019 | EYEN | EYENOVIA, INC. | LEE KENNETH B JR | Director | Option Exercise | A | 3.11 | 9,057 | 28,167 | 9,057 | |
Aug 20 2019 | EYEN | EYENOVIA, INC. | LEE KENNETH B JR | Director | Grant | A | 0.00 | 8,038 | 0 | 12,071 | 4 K to 12.1 K (+199.31 %) |
May 31 2019 | BCRX | BIOCRYST PHARMACEU ... | LEE KENNETH B JR | Director | Option Exercise | A | 2.91 | 30,000 | 87,300 | 30,000 | |
Jul 26 2018 | EYEN | EYENOVIA, INC. | LEE KENNETH B JR | Director | Option Exercise | A | 6.20 | 4,465 | 27,683 | 4,465 | |
Jul 26 2018 | EYEN | EYENOVIA, INC. | LEE KENNETH B JR | Director | Grant | A | 0.00 | 4,033 | 0 | 4,033 | 0 to 4 K |
Jun 22 2018 | BCRX | BIOCRYST PHARMACEU ... | LEE KENNETH B JR | Director | Option Exercise | A | 6.09 | 30,000 | 182,700 | 30,000 | |
May 25 2017 | BCRX | BIOCRYST PHARMACEU ... | LEE KENNETH B JR | Director | Option Exercise | A | 5.13 | 30,000 | 153,900 | 30,000 | |
May 12 2017 | ARLZ | Aralez Pharmaceuti ... | LEE KENNETH B JR | Director | Option Exercise | A | 1.56 | 15,000 | 23,400 | 15,000 | |
May 12 2017 | ARLZ | Aralez Pharmaceuti ... | LEE KENNETH B JR | Director | Grant | A | 0.00 | 7,500 | 0 | 102,952 | 95.5 K to 103 K (+7.86 %) |
Nov 15 2016 | ARLZ | Aralez Pharmaceuti ... | LEE KENNETH B JR | Director | Buy | P | 4.95 | 1,000 | 4,950 | 90,452 | 89.5 K to 90.5 K (+1.12 %) |
Jun 20 2016 | ARLZ | Aralez Pharmaceuti ... | LEE KENNETH B JR | Director | Option Exercise | A | 3.42 | 15,000 | 51,300 | 15,000 | |
Jun 20 2016 | ARLZ | Aralez Pharmaceuti ... | LEE KENNETH B JR | Director | Grant | A | 0.00 | 7,500 | 0 | 89,452 | 82 K to 89.5 K (+9.15 %) |
Jun 14 2016 | ARLZ | Aralez Pharmaceuti ... | LEE KENNETH B JR | Director | Payment of Exercise | F | 3.58 | 1,404 | 5,026 | 81,952 | 83.4 K to 82 K (-1.68 %) |
May 25 2016 | BCRX | BIOCRYST PHARMACEU ... | LEE KENNETH B JR | Director | Option Exercise | A | 3.22 | 30,000 | 96,600 | 30,000 | |
May 17 2016 | ARLZ | Aralez Pharmaceuti ... | LEE KENNETH B JR | Director | Buy | P | 3.50 | 1,000 | 3,500 | 83,356 | 82.4 K to 83.4 K (+1.21 %) |
Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | LEE KENNETH B JR | Director | Option Exercise | J | 13.26 | 6,107 | 80,979 | 6,107 | |
Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | LEE KENNETH B JR | Director | Buy | J | 0.00 | 72,966 | 0 | 72,966 | 0 to 73 K |
Jun 25 2015 | POZN | POZEN INC /NC | LEE KENNETH B JR | Director | Option Exercise | M | 4.44 | 6,107 | 27,115 | 0 | |
Jun 25 2015 | POZN | POZEN INC /NC | LEE KENNETH B JR | Director | Option Exercise | M | 5.40 | 6,107 | 32,978 | 0 | |
Jun 25 2015 | POZN | POZEN INC /NC | LEE KENNETH B JR | Director | Option Exercise | M | 3.84 | 6,107 | 23,451 | 0 | |
Jun 25 2015 | POZN | POZEN INC /NC | LEE KENNETH B JR | Director | Option Exercise | M | 5.97 | 6,107 | 36,459 | 0 | |
Jun 25 2015 | POZN | POZEN INC /NC | LEE KENNETH B JR | Director | Option Exercise | M | 6.35 | 6,107 | 38,779 | 0 | |
Jun 25 2015 | POZN | POZEN INC /NC | LEE KENNETH B JR | Director | Option Exercise | M | 11.83 | 6,107 | 72,246 | 0 | |
Jun 25 2015 | POZN | POZEN INC /NC | LEE KENNETH B JR | Director | Option Exercise | M | 8.62 | 24,430 | 210,587 | 0 | |
Jun 25 2015 | POZN | POZEN INC /NC | LEE KENNETH B JR | Director | Payment of Exercise | F | 12.02 | 36,743 | 441,651 | 72,966 | 109.7 K to 73 K (-33.49 %) |
Jun 25 2015 | POZN | POZEN INC /NC | LEE KENNETH B JR | Director | Buy | M | 4.44 | 6,107 | 27,115 | 109,709 | 103.6 K to 109.7 K (+5.89 %) |
Jun 25 2015 | POZN | POZEN INC /NC | LEE KENNETH B JR | Director | Buy | M | 5.40 | 6,107 | 32,978 | 103,602 | 97.5 K to 103.6 K (+6.26 %) |
Jun 25 2015 | POZN | POZEN INC /NC | LEE KENNETH B JR | Director | Buy | M | 3.84 | 6,107 | 23,451 | 97,495 | 91.4 K to 97.5 K (+6.68 %) |
Jun 25 2015 | POZN | POZEN INC /NC | LEE KENNETH B JR | Director | Buy | M | 5.97 | 6,107 | 36,459 | 91,388 | 85.3 K to 91.4 K (+7.16 %) |
Jun 25 2015 | POZN | POZEN INC /NC | LEE KENNETH B JR | Director | Buy | M | 6.35 | 6,107 | 38,779 | 85,281 | 79.2 K to 85.3 K (+7.71 %) |
Jun 25 2015 | POZN | POZEN INC /NC | LEE KENNETH B JR | Director | Buy | M | 11.83 | 6,107 | 72,246 | 79,174 | 73.1 K to 79.2 K (+8.36 %) |
Jun 25 2015 | POZN | POZEN INC /NC | LEE KENNETH B JR | Director | Buy | M | 8.62 | 24,430 | 210,587 | 73,067 | 48.6 K to 73.1 K (+50.23 %) |
Jun 12 2015 | POZN | POZEN INC /NC | LEE KENNETH B JR | Director | Grant | A | 0.00 | 9,390 | 0 | 58,027 | 48.6 K to 58 K (+19.31 %) |
May 22 2015 | BCRX | BIOCRYST PHARMACEU ... | LEE KENNETH B JR | Director | Option Exercise | A | 11.39 | 15,000 | 170,850 | 15,000 | |
Jun 08 2004 | ABGX | ABGENIX INC | LEE KENNETH B JR | Director | Option Exercise | A | 13.36 | 15,000 | 200,400 | 15,000 |
Page: 1